In the past decades, several biomarkers were discovered, for example, epidermal growth factor receptor (EGFR) in lung cancer patients [2] and hormone receptor (HR), human epidermal growth factor receptor 2 (HER2), estrogen (ER), progesterone receptor (PR) in breast cancer patients [3, 4]. This evidence concerns the gene EGFR and breast carcinoma.